1. Home
  2. PTLE vs SABS Comparison

PTLE vs SABS Comparison

Compare PTLE & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • SABS
  • Stock Information
  • Founded
  • PTLE 2013
  • SABS 2014
  • Country
  • PTLE Singapore
  • SABS United States
  • Employees
  • PTLE N/A
  • SABS N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • SABS Health Care
  • Exchange
  • PTLE Nasdaq
  • SABS Nasdaq
  • Market Cap
  • PTLE 16.4M
  • SABS 15.8M
  • IPO Year
  • PTLE 2024
  • SABS N/A
  • Fundamental
  • Price
  • PTLE $0.22
  • SABS $2.64
  • Analyst Decision
  • PTLE
  • SABS Strong Buy
  • Analyst Count
  • PTLE 0
  • SABS 5
  • Target Price
  • PTLE N/A
  • SABS $11.80
  • AVG Volume (30 Days)
  • PTLE 26.5M
  • SABS 35.4K
  • Earning Date
  • PTLE 02-21-2025
  • SABS 08-07-2025
  • Dividend Yield
  • PTLE N/A
  • SABS N/A
  • EPS Growth
  • PTLE N/A
  • SABS N/A
  • EPS
  • PTLE N/A
  • SABS N/A
  • Revenue
  • PTLE $98,133,646.00
  • SABS $377,835.00
  • Revenue This Year
  • PTLE N/A
  • SABS N/A
  • Revenue Next Year
  • PTLE N/A
  • SABS N/A
  • P/E Ratio
  • PTLE N/A
  • SABS N/A
  • Revenue Growth
  • PTLE N/A
  • SABS N/A
  • 52 Week Low
  • PTLE $0.17
  • SABS $1.00
  • 52 Week High
  • PTLE $15.78
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • PTLE N/A
  • SABS 77.22
  • Support Level
  • PTLE N/A
  • SABS $1.72
  • Resistance Level
  • PTLE N/A
  • SABS $2.72
  • Average True Range (ATR)
  • PTLE 0.00
  • SABS 0.19
  • MACD
  • PTLE 0.00
  • SABS 0.10
  • Stochastic Oscillator
  • PTLE 0.00
  • SABS 91.89

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: